Candida Auris Features and its Treatment

Fungal pathogen Candida auris was identified in 2009, in Japan. Currently, it is identified in 5 continents, in more than 40 countries. Therefore, it is nowadays defined as critical priority pathogen. The present mini-review describes the resistance to medicines that are currently in use and these drugs’ resistance to antimicrobial mechanisms (RAM). Furthermore, therapies and the on-going search for future drugs will also be discussed.